Delivery Order SPE2D021DA002-SPE2D326F2315
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,279.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector sets. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $1,045.50. Issued on December 1, 2025, with an ultimate completion date of December 2, 2025, this firm fixed-price delivery order represents a routine procurement under the company's existing pharmaceutical supply contract....
- The Defense Logistics Agency's Medical Supply Chain division awarded a $3,833.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is expected to be completed by September 5, 2025, and represents performance at the vendor's Park...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, valued at $2,590.25, was awarded on November 26, 2025, with completion scheduled for November 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector units (quantity 2). This firm fixed-price delivery order, valued at $1,742.50, was issued on October 2, 2025, with an ultimate completion date of October 3, 2025, and does not include a set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,742.50 on December 10, 2025, for the supply of epinephrine 0.3 mg auto-injector units. This firm fixed-price delivery order, which carries an ultimate completion date of December 11, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Epinephrine 0.3 mg auto-injector (2 units). The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. Performance will be executed in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. The award, issued on September 5, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Park Ridge location. The...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F2315Delivery Order
The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,742.50 to DMS Pharmaceutical Group Inc. for the supply of epinephrine 0.3 mg auto-injector (2-pack) with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was awarded without set-aside designation on December 8, 2025, and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, has been registered in the System for Award Management since 2001 and specializes in distributing a comprehensive range of pharmaceutical products and medical consumables to federal agencies. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, and represents a 30-month base period with three 30-month option periods. The PPV-G GEN V is part of a broader $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply pharmaceuticals, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/7/25 |